Flurbiprofen axetil

DB14938InvestigationalSmall molecule

Flurbiprofen axetil is under investigation in clinical trial NCT02043366 (Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients).

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor gamma, Prostaglandin G/H synthase 2, and Human Cyclooxygenases
Curator reviewed
Formula / weight: C₁₉H₁₉FO₄ · 330.355 g/mol (avg)

Resolves to

Compound

UNIII0OU31PUI5CAS91503-79-6ChEMBLCHEMBL3183067ChEBI31627

Structure

InChIKeyALIVXCSEERJYHU-UHFFFAOYSA-NSMILESCC(OC(C)=O)OC(=O)C(C)C1=CC(F)=C(C=C1)C1=CC=CC=C1

Targets

P37231PPARGP35354PTGS2

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

659Drug interactionsStructured to mechanism, not free text

22Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Flurbiprofen axetil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account